{"ticker": "LIPO", "overview": {"cik": "1347242", "ticker": "LIPO", "name": "LIPELLA PHARMACEUTICALS INC.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "8-K", "date": "2026-07-15", "title": "FORM 8-K", "accession": "0001753926-26-001173", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-31", "title": "FORM 8-K", "accession": "0001753926-26-000577", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-04", "title": "Material event", "accession": "0001753926-26-000265", "price_sensitive": true}, {"form": "10-Q", "date": "2025-11-14", "title": "FORM 10Q", "accession": "0001753926-25-001805", "price_sensitive": true}, {"form": "8-K", "date": "2025-10-21", "title": "Material event", "accession": "0001753926-25-001636", "price_sensitive": true}, {"form": "8-K", "date": "2025-10-09", "title": "Material event", "accession": "0001753926-25-001602", "price_sensitive": true}, {"form": "25-NSE", "date": "2025-10-06", "title": "Form 25-NSE", "accession": "0001354457-25-000985", "price_sensitive": false}, {"form": "8-K", "date": "2025-09-18", "title": "Material event", "accession": "0001753926-25-001525", "price_sensitive": true}, {"form": "10-Q", "date": "2025-08-14", "title": "Quarterly report", "accession": "0001753926-25-001347", "price_sensitive": true}, {"form": "8-K", "date": "2025-06-25", "title": "Material event", "accession": "0001753926-25-001003", "price_sensitive": true}, {"form": "8-K", "date": "2025-06-20", "title": "FORM 8-K", "accession": "0001753926-25-000984", "price_sensitive": true}, {"form": "8-K", "date": "2025-06-16", "title": "Material event", "accession": "0001753926-25-000962", "price_sensitive": true}, {"form": "PRE 14A", "date": "2025-06-10", "title": "Form PRE 14A", "accession": "0001753926-25-000952", "price_sensitive": false}, {"form": "8-K", "date": "2025-05-16", "title": "Material event", "accession": "0001753926-25-000856", "price_sensitive": true}, {"form": "8-K", "date": "2025-05-15", "title": "Material event", "accession": "0001753926-25-000842", "price_sensitive": true}, {"form": "10-Q", "date": "2025-05-14", "title": "Quarterly report", "accession": "0001753926-25-000818", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2025-05-01", "title": "Form SCHEDULE 13G/A", "accession": "0001753926-25-000727", "price_sensitive": false}, {"form": "8-K", "date": "2025-04-14", "title": "Material event", "accession": "0001753926-25-000623", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2025-04-09", "title": "Form SCHEDULE 13D/A", "accession": "0001753926-25-000614", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-04-09", "title": "Form SCHEDULE 13D/A", "accession": "0001753926-25-000612", "price_sensitive": false}, {"form": "8-K", "date": "2025-04-09", "title": "Material event", "accession": "0001753926-25-000604", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2025-04-07", "title": "Form SCHEDULE 13D/A", "accession": "0001753926-25-000592", "price_sensitive": false}, {"form": "4", "date": "2025-04-07", "title": "Insider transaction", "accession": "0001753926-25-000590", "price_sensitive": false}, {"form": "8-K", "date": "2025-04-07", "title": "Material event", "accession": "0001753926-25-000585", "price_sensitive": true}, {"form": "424B5", "date": "2025-04-04", "title": "Prospectus", "accession": "0001753926-25-000582", "price_sensitive": false}]}, "description": "", "exchange": null, "stats": {"buy_n": 2, "buy_sum": 53041.5, "sell_n": 0, "sell_sum": 0, "net": 53041.5, "insiders": 1, "first_date": "2024-03-19", "last_date": "2024-05-14"}, "metrics": {"ticker": "LIPO", "has_prices": false}, "trades": [{"id": "0001753926-25-000590", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392625000590/0001753926-25-000590-index.htm", "trade_date": "2025-04-03", "timestamp": "2025-04-03", "mins": 833261}, {"id": "0001753926-25-000459", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392625000459/0001753926-25-000459-index.htm", "trade_date": "2025-03-13", "timestamp": "2025-03-13", "mins": 863501}, {"id": "0001753926-25-000427", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392625000427/0001753926-25-000427-index.htm", "trade_date": "2025-03-10", "timestamp": "2025-03-10", "mins": 867821}, {"id": "0001753926-25-000384", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392625000384/0001753926-25-000384-index.htm", "trade_date": "2025-02-28", "timestamp": "2025-02-28", "mins": 882221}, {"id": "0001753926-25-000101", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392625000101/0001753926-25-000101-index.htm", "trade_date": "2025-01-15", "timestamp": "2025-01-15", "mins": 945581}, {"id": "0001753926-25-000019", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392625000019/0001753926-25-000019-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967181}, {"id": "0001753926-24-002182", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624002182/0001753926-24-002182-index.htm", "trade_date": "2024-12-23", "timestamp": "2024-12-23", "mins": 978701}, {"id": "0001753926-24-000984", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 7590.0, "score": 26.4, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board insider adds $8K of LIPO", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000984/0001753926-24-000984-index.htm", "trade_date": "2024-05-14", "timestamp": "2024-05-14", "mins": 1299821}, {"id": "0001753926-24-000573", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 45451.5, "score": 35.5, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The boardroom is buying: $45K of LIPO", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000573/0001753926-24-000573-index.htm", "trade_date": "2024-03-19", "timestamp": "2024-03-19", "mins": 1380461}, {"id": "0001753926-24-000567", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Byong Kim", "who_key": "Kim Byong", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000567/0001753926-24-000567-index.htm", "trade_date": "2024-03-15", "timestamp": "2024-03-15", "mins": 1386221}, {"id": "0001753926-24-000569", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Daniel R. Cohen", "who_key": "Cohen Daniel R", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000569/0001753926-24-000569-index.htm", "trade_date": "2024-03-15", "timestamp": "2024-03-15", "mins": 1386221}, {"id": "0001753926-24-000571", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Douglas Johnston", "who_key": "Johnston Douglas", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000571/0001753926-24-000571-index.htm", "trade_date": "2024-03-15", "timestamp": "2024-03-15", "mins": 1386221}, {"id": "0001753926-24-000575", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Lori Birder", "who_key": "Birder Lori", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000575/0001753926-24-000575-index.htm", "trade_date": "2024-03-15", "timestamp": "2024-03-15", "mins": 1386221}, {"id": "0001753926-24-000577", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Michael B. Chancellor", "who_key": "Chancellor Michael B", "role": "Chief Medical Officer, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000577/0001753926-24-000577-index.htm", "trade_date": "2024-03-15", "timestamp": "2024-03-15", "mins": 1386221}, {"id": "0001753926-24-000579", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Naoki Yoshimura", "who_key": "Yoshimura Naoki", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000579/0001753926-24-000579-index.htm", "trade_date": "2024-03-15", "timestamp": "2024-03-15", "mins": 1386221}, {"id": "0001753926-24-000581", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Ryan Pruchnic", "who_key": "Pruchnic Ryan", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000581/0001753926-24-000581-index.htm", "trade_date": "2024-03-15", "timestamp": "2024-03-15", "mins": 1386221}, {"id": "0001753926-24-000539", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Michael B. Chancellor", "who_key": "Chancellor Michael B", "role": "Chief Medical Officer, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 99999.6306, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000539/0001753926-24-000539-index.htm", "trade_date": "2024-03-13", "timestamp": "2024-03-13", "mins": 1389101}, {"id": "0001753926-24-000541", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 99999.6306, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000541/0001753926-24-000541-index.htm", "trade_date": "2024-03-13", "timestamp": "2024-03-13", "mins": 1389101}, {"id": "0001753926-23-000821", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Douglas Johnston", "who_key": "Johnston Douglas", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000821/0001753926-23-000821-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-23-000823", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Byong Kim", "who_key": "Kim Byong", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000823/0001753926-23-000823-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-23-000825", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Naoki Yoshimura", "who_key": "Yoshimura Naoki", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000825/0001753926-23-000825-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-23-000827", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Michael B. Chancellor", "who_key": "Chancellor Michael B", "role": "Chief Medical Officer, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000827/0001753926-23-000827-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-23-000829", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000829/0001753926-23-000829-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-23-000831", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Ryan Pruchnic", "who_key": "Pruchnic Ryan", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000831/0001753926-23-000831-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-23-000833", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "David S. Battleman", "who_key": "Battleman David S.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000833/0001753926-23-000833-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-23-000835", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Daniel R. Cohen", "who_key": "Cohen Daniel R", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392623000835/0001753926-23-000835-index.htm", "trade_date": "2023-06-16", "timestamp": "2023-06-16", "mins": 1779341}, {"id": "0001753926-22-001648", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC", "who": "Michael B. Chancellor", "who_key": "Chancellor Michael B", "role": "Chief Medical Officer, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 131962.5, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on LIPO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392622001648/0001753926-22-001648-index.htm", "trade_date": "2022-12-22", "timestamp": "2022-12-22", "mins": 2032781}], "recent_buys": [{"id": "0001753926-24-000984", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 7590.0, "score": 26.4, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board insider adds $8K of LIPO", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000984/0001753926-24-000984-index.htm", "trade_date": "2024-05-14", "timestamp": "2024-05-14", "mins": 1299821}, {"id": "0001753926-24-000573", "src": "INSIDERS", "ticker": "LIPO", "cik": "1347242", "company": "LIPELLA PHARMACEUTICALS INC.", "company_raw": "LIPELLA PHARMACEUTICALS INC.", "who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 45451.5, "score": 35.5, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The boardroom is buying: $45K of LIPO", "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000573/0001753926-24-000573-index.htm", "trade_date": "2024-03-19", "timestamp": "2024-03-19", "mins": 1380461}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "Removed from the exchange (2025)", "items": [{"action": "DELISTED", "reason": "EXCHANGE_DELISTING", "counterparty": null, "old_value": "LIPO", "new_value": "Removed from the exchange", "effective": "2025-10-06", "evidence": "Form 25-NSE filed 2025-10-06", "source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001347242", "applied": 1, "detected_at": "2026-08-03T11:18:42.664886"}, {"action": "DELISTED", "reason": "UNKNOWN", "counterparty": null, "old_value": "LIPO", "new_value": "No longer listed", "effective": "", "evidence": "No longer in the listed universe; we have no source stating why.", "source_url": "", "applied": 1, "detected_at": "2026-08-03T11:13:39.867761"}]}, "key_people": [{"who": "Jonathan H. Kaufman", "who_key": "Kaufman Jonathan H", "role": "See remarks below., Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "bought": 53041.5, "sold": 0, "net": 53041.5, "trades": 2, "top_score": 35.5, "lean": "buying", "history": [{"action": "BUY", "amount": 7590.0, "date": "2024-05-14", "score": 26.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000984/0001753926-24-000984-index.htm"}, {"action": "BUY", "amount": 45451.5, "date": "2024-03-19", "score": 35.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000573/0001753926-24-000573-index.htm"}], "latest": {"action": "BUY", "amount": 7590.0, "date": "2024-05-14", "score": 26.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1347242/000175392624000984/0001753926-24-000984-index.htm"}}], "activity": [], "announcements": [{"form": "8-K", "date": "2026-07-15", "title": "FORM 8-K", "accession": "0001753926-26-001173", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-31", "title": "FORM 8-K", "accession": "0001753926-26-000577", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-04", "title": "Material event", "accession": "0001753926-26-000265", "price_sensitive": true}, {"form": "10-Q", "date": "2025-11-14", "title": "FORM 10Q", "accession": "0001753926-25-001805", "price_sensitive": true}, {"form": "8-K", "date": "2025-10-21", "title": "Material event", "accession": "0001753926-25-001636", "price_sensitive": true}, {"form": "8-K", "date": "2025-10-09", "title": "Material event", "accession": "0001753926-25-001602", "price_sensitive": true}, {"form": "25-NSE", "date": "2025-10-06", "title": "Form 25-NSE", "accession": "0001354457-25-000985", "price_sensitive": false}, {"form": "8-K", "date": "2025-09-18", "title": "Material event", "accession": "0001753926-25-001525", "price_sensitive": true}, {"form": "10-Q", "date": "2025-08-14", "title": "Quarterly report", "accession": "0001753926-25-001347", "price_sensitive": true}, {"form": "8-K", "date": "2025-06-25", "title": "Material event", "accession": "0001753926-25-001003", "price_sensitive": true}, {"form": "8-K", "date": "2025-06-20", "title": "FORM 8-K", "accession": "0001753926-25-000984", "price_sensitive": true}, {"form": "8-K", "date": "2025-06-16", "title": "Material event", "accession": "0001753926-25-000962", "price_sensitive": true}, {"form": "PRE 14A", "date": "2025-06-10", "title": "Form PRE 14A", "accession": "0001753926-25-000952", "price_sensitive": false}, {"form": "8-K", "date": "2025-05-16", "title": "Material event", "accession": "0001753926-25-000856", "price_sensitive": true}, {"form": "8-K", "date": "2025-05-15", "title": "Material event", "accession": "0001753926-25-000842", "price_sensitive": true}, {"form": "10-Q", "date": "2025-05-14", "title": "Quarterly report", "accession": "0001753926-25-000818", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2025-05-01", "title": "Form SCHEDULE 13G/A", "accession": "0001753926-25-000727", "price_sensitive": false}, {"form": "8-K", "date": "2025-04-14", "title": "Material event", "accession": "0001753926-25-000623", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2025-04-09", "title": "Form SCHEDULE 13D/A", "accession": "0001753926-25-000614", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-04-09", "title": "Form SCHEDULE 13D/A", "accession": "0001753926-25-000612", "price_sensitive": false}, {"form": "8-K", "date": "2025-04-09", "title": "Material event", "accession": "0001753926-25-000604", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2025-04-07", "title": "Form SCHEDULE 13D/A", "accession": "0001753926-25-000592", "price_sensitive": false}, {"form": "4", "date": "2025-04-07", "title": "Insider transaction", "accession": "0001753926-25-000590", "price_sensitive": false}, {"form": "8-K", "date": "2025-04-07", "title": "Material event", "accession": "0001753926-25-000585", "price_sensitive": true}, {"form": "424B5", "date": "2025-04-04", "title": "Prospectus", "accession": "0001753926-25-000582", "price_sensitive": false}], "performance": {"ticker": "LIPO", "has_prices": false, "summary": null, "buys": [{"who": "Kaufman Jonathan H", "person_type": "EXEC", "person_label": "Execs", "role": "See remarks below., Director, 10% Owner", "amount": 7590.0, "date": "2024-05-14", "score": 26.4, "ref_price": null, "return": null}, {"who": "Kaufman Jonathan H", "person_type": "EXEC", "person_label": "Execs", "role": "See remarks below., Director, 10% Owner", "amount": 45451.5, "date": "2024-03-19", "score": 35.5, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}